Pfizer Inc. (PFE) announced Tuesday the expansion of 'An Accord for a Healthier World' product offering to include the full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to lower-income countries.
The Accord, launched in May 2022, is an initiative focused to reduce health inequities between many lower-income countries and the rest of the world.
The expanded product offering will include off-patent products, bringing the total offering to around 500 products from 23 products. It will give health benefits to 1.2 billion people living in 45 lower-income countries.
Pfizer's initial commitment to the Accord included access to all its patented medicines and vaccines available in the U.S. or European Union on a not-for-profit basis to 45 lower-income countries.
The Accord portfolio offering now includes both patented and off-patent medicines and vaccines that treat or prevent many infectious and non-communicable disease threats faced in lower-income countries.
As Pfizer launches new medicines and vaccines, those products will also be included in the Accord portfolio on a not-for-profit basis.
For More Such Health News, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News